Biohaven Pharmaceutical Holding Company Ltd.
NYSE:BHVN
39.31 (USD) • At close February 4, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Biohaven Pharmaceutical Holding Company Ltd. |
Symbool | BHVN |
Munteenheid | USD |
Prijs | 39.31 |
Beurswaarde | 3,975,115,490 |
Dividendpercentage | 0% |
52-weken bereik | 26.8 - 62.21 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Vladimir Coric M.D. |
Website | https://www.biohavenpharma.com |
An error occurred while fetching data.
Over Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)